Enoxaparin sodium
Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI) .
Product Specifications
CAS Number
679809-58-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
1322
Molecular Formula
C42H59N3Na4O35S2
Notes
Research use only, not for human use.
Receptor
Parasite|N-myristoyltransferase-1 (NMT-1)
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS8104826-01 0.02 mL
Anti-H7N9 Hemagglutinin/HA Antibody, Hemagglutination Inhibition Activity, Rabbit MAb
Ask
View Details MBS8104826-02 0.1 mL
Anti-H7N9 Hemagglutinin/HA Antibody, Hemagglutination Inhibition Activity, Rabbit MAb
Ask
View Details 
MBS8104826-03 5x 0.1 mL
Anti-H7N9 Hemagglutinin/HA Antibody, Hemagglutination Inhibition Activity, Rabbit MAb
Ask
View Details 
MBS6007006-01 0.05 mg
SENP1, NT (Sentrin-specific Protease 1, Sentrin/SUMO-specific Protease SENP1, SEN1)
Ask
View Details MBS6007006-02 5x 0.05 mg
SENP1, NT (Sentrin-specific Protease 1, Sentrin/SUMO-specific Protease SENP1, SEN1)
Ask
View Details